Loading…

Loading grant details…

Active HORIZON European Commission

Implementation of superior treatment regimen and improved patient pathway for neurocysticercosis in Sub-Saharan Africa

€4.23M EUR

Funder European Commission
Recipient Organization R-Evolution Worldwide Srl - Impresa Sociale
Country Italy
Start Date May 01, 2023
End Date Apr 30, 2027
Duration 1,460 days
Number of Grantees 5
Roles Participant; Coordinator
Data Source European Commission
Grant ID 101103306
Grant Description

Neurocysticercosis (NCC) is a fatal zoonotic disease following ingestion of eggs of the pork tapeworm, Taenia solium.

The eggs develop to larval forms (cysticerci) in various tissues, including those of the central nervous system, leading to NCC, mainly characterized by epileptic seizures. NCC management guidelines have been published by the WHO, however, their uptake in national policies is very limited.

In NeuroSolve, we will demonstrate and promote a methodological approach for conducting health research that leads to improved adoption into policy and clinical practise.

We will validate the approach by investigating evaluation- and implementation of an antiparasitic combination treatment and a serological test. Two health innovations that can make a major positive contribution to NCC management.

The proposed approach includes (1) strengthening of clinical and research capacity through training and mentoring of early career researchers, clinicians and frontline healthcare workers as well as upgrading infrastructure for surveillance and control, (2) demonstrating the improved pragmatic effectiveness of the combined treatment on quality of life (3) evaluating the potential impact of serological testing on the patient outcomes and the wider health system through a simulation study, (4) demonstrating the cost-effectiveness and cost-benefit of the proposed health technologies, (5) developing and validating an implementation strategy that addresses identified barriers for uptake using the robust implementation frameworks and 6) enhance research results uptake into national and international guidelines and health policy through engagement of relevant policy makers throughout the project period and beyond.

If the intended impacts are reached, NeuroSolve will improve health outcomes of NCC patients, provide a blueprint for meaningful implementation research and demonstrate to policy makers how research can strengthen healthcare systems.

All Grantees

Universiteit Gent; Sokoine University of Agriculture; University of Dar Es Salaam; R-Evolution Worldwide Srl - Impresa Sociale; University of Zambia

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant